Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where the trifluoromethyl and fluoro substituents enhance metabolic stability and binding affinity. Commonly employed in the production of anti-inflammatory, antifungal, and central nervous system agents. Its structure supports improved lipophilicity and bioavailability in drug candidates. Also utilized in agrochemicals for the preparation of fluorinated pesticides and herbicides, taking advantage of its electron-withdrawing properties to increase compound efficacy. Suitable for use in cross-coupling reactions and other transformations in medicinal chemistry research.